# T-Cell Therapy (ECT204) in Adults With Advanced HCC

> **NCT04864054** · PHASE1,PHASE2 · RECRUITING · sponsor: **Eureka Therapeutics Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer, Adult
- Liver Neoplasm
- Metastatic Liver Cancer

## Interventions

- **BIOLOGICAL:** ECT204 T cells

## Key facts

- **NCT ID:** NCT04864054
- **Lead sponsor:** Eureka Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-11
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864054, "T-Cell Therapy (ECT204) in Adults With Advanced HCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04864054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*